Arthrosamid Hydrogel Injections For Knee Osteoarthritis Pain: Guide Released

The latest guide covers the mechanics behind arthrosamid, an emerging modality that was recently approved for the European market and is being adopted worldwide as a treatment for knee osteoarthritis. Individuals who suffer from chronic pain and mobility issues caused by the condition can read the guide to explore why it is recommended as a safe and effective non-surgical option for long-term pain management and whether the treatment is suitable for them.

For more information, please visit https://mskdoctors.com/treatments/arthrosamid

Arthrosamid was first conceived two decades ago and has been the subject of rigorous research as it developed over the years. In April 2021, the treatment received the CE mark – which denotes approval for the European market – after individuals who underwent the procedure as part of a year-long study reported experiencing a significant reduction in knee osteoarthritis pain within four weeks. Additional studies have shown that the effects of arthrosamid can last for at least two years, making it more effective than other types of knee injections and suggesting that it can postpone and potentially eliminate the need for knee replacement surgery.

MSK Doctors’ guide explains that arthrosamid is a synthetic, non-degradable hydrogel that is injected into the knee joint, where it permanently integrates with the synovial membrane. This improves lubrication and provides cushioning for the joint, reducing friction between bones and alleviating pain and stiffness. Numerous clinical trials have shown that there are no serious side effects associated with the treatment, with the most commonly reported symptom being temporary mild to moderate pain and swelling at the injection site.

MSK Doctors’ guide says that arthrosamid procedures also tend to result in minimal downtime, hastening the patient’s recovery and allowing them to return to their daily activities more quickly. Although individuals who undergo the procedure must avoid high-impact or strenuous weight-bearing exercises for a few days after the injection, they will be able to gradually reintroduce more activity into their routine as time passes.

At MSK Doctors, arthrosamid injections are offered by Professor Paul Lee and other veteran orthopaedic surgeons. Individuals interested in their eligibility can contact the practice for more details.

Additional information is available at https://mskdoctors.com/

MSK Doctors

MSK House London Road
Silk Willoughby, Sleaford, Lincolnshire
Sleaford
England
NG34 8NY
United Kingdom